Alumis, Inc. (ALMS)
22.38
-0.83
(-3.58%)
USD |
NASDAQ |
Aug 28, 16:00
22.36
-0.02
(-0.09%)
After-Hours: 20:00
Alumis Cash from Investing (Quarterly) : 68.69M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 68.69M |
| March 31, 2026 | -285.69M |
| December 31, 2025 | 95.01M |
| September 30, 2025 | 24.04M |
| June 30, 2025 | 129.40M |
| March 31, 2025 | 39.43M |
| December 31, 2024 | 30.95M |
| Date | Value |
|---|---|
| September 30, 2024 | -93.19M |
| June 30, 2024 | -32.74M |
| March 31, 2024 | -18.81M |
| December 31, 2023 | -4.144M |
| September 30, 2023 | 7.576M |
| June 30, 2023 | 25.98M |
| March 31, 2023 | 31.06M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -29.24M |
| Aclaris Therapeutics, Inc. | 10.26M |
| Crinetics Pharmaceuticals, Inc. | 26.29M |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Veru, Inc. | 1.802M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -81.50M |
| Cash from Financing (Quarterly) | 12.63M |
| Free Cash Flow | -351.80M |
| Free Cash Flow Per Share (Quarterly) | -0.6401 |
| Free Cash Flow to Equity (Quarterly) | -82.50M |
| Free Cash Flow to Firm (Quarterly) | -81.74M |
| Free Cash Flow Yield | -13.62% |